BIOS — Biosenic SA Balance Sheet
0.000.00%
Annual balance sheet for Biosenic SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.7 | 1.85 | 0.117 | 0.343 | 0.069 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.91 | 2.41 | 1.44 | 4.21 | 2.85 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 14.3 | 4.63 | 1.85 | 4.56 | 2.92 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.863 | 1.42 | 0.698 | 0.111 | 0.003 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 19.8 | 29.3 | 9.56 | 5.48 | 3.42 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.67 | 10.4 | 15.8 | 8.31 | 5.34 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.5 | 25.8 | 32.5 | 29.4 | 5.37 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -6.76 | 3.53 | -22.9 | -23.9 | -1.96 |
| Total Liabilities & Shareholders' Equity | 19.8 | 29.3 | 9.56 | 5.48 | 3.42 |
| Total Common Shares Outstanding |